Last update: Dec. 1, 2004

Benfluorex-Hcl

Very High Risk for breastfeeding


Very unsafe. Contraindicated.
Use of an alternative or cessation of breastfeeding.

It has been market for serum lipid control in Spain. In fact it is an adrenergic-agonist drug which is used for obesity treatment. It may be a cause of insomnia, anorexia and irritability. Breastfeeding women return to pre-pregnancy body weight sooner than bottle-feeding mothers.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Benfluorex-Hcl belongs to this group or family:

Tradenames

Main tradenames from several countries containing Benfluorex-Hcl in its composition:

Pharmacokinetics

Variable Value Unit
Molecular weight 351 daltons
Tmax 2 hours

References

We are working to add the scientific references of this product. It will be available soon. If you wish to have access to this information, please let us know by leaving your comment in the opinion section below.

Total visits

1,820

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche de Euskadi

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM